Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris: A 3-Month Randomised, Double-Blind, Multicentre, Noninferiority Trial

By Ruzyllo Witold  

Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. : 393-405

Adis International

Access to resources Recommend Favorite

Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)

By Malerba M.   Ponticiello A.   Radaeli A.   Bensi G.   Grassi V.  

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite

Antianginal Effects of Trimetazidine and Left Ventricular Function Improvement in Patients with Stable Angina Pectoris

By Shlyakhto E.V.   Almazov V.V.A.   Nifontov E.M.   Vakhrameyeva I.V.   Rudomanov O.G.   Zakharov D.V.   Kazarin V.V.   Vakhrameyeva N.V.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. : 119-124

Adis International

Access to resources Recommend Favorite

Effect of Ivabradine, a Novel Antianginal Agent, on Driving Performance: A Randomized, Double-Blind, Placebo-Controlled Trial in Healthy Volunteers

By Macher Jean-Paul  

Clinical Drug Investigation, Vol. 29, Iss. 5, 2009-01 ,pp. : 339-348

Adis International

Access to resources Recommend Favorite

Lack of Anti-Ischemic Efficacy of the Potassium Channel Opener Bimakalim in Patients with Stable Angina Pectoris

By Burian Maria   Piske Michael   Petkovic Draga   Mitrovic Veselin  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 37-46

Springer Publishing Company

Access to resources Recommend Favorite